However, treatment with FGF10 resulted in a significant increase in the percent of time spent in the center of the open field, improved object discrimination index, and reduced escape latency and path length in the Morris water maze, suggesting that FGF10 may alleviate depression, anxiety, and cognitive deficits in AD. This evidence concerns the gene FGF10 and depressive symptom measurement.